Vantage logo

The lung fibrosis pipeline thins

This month Pliant Therapeutics claimed a win in idiopathic pulmonary fibrosis, but other projects have fallen by the wayside.

Vantage logo

Covid-19 research efforts slow

A few developers are still finding reasons to research novel pandemic treatments, though much of the ongoing work is focused on proven approaches.